Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001676 |
---|---|
Receipt number | R000002024 |
Scientific Title | Multicenter cohort study to investigate the risk of metachronous multiple cancers and assess the period required for their development after EMR, using Lugol-voiding pattern as a biomarker in patients with esophageal squamous cell carcinoma |
Date of disclosure of the study information | 2009/01/31 |
Last modified on | 2021/10/13 21:35:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/01/31 14:54:49 | ||
2 | Update | 2010/01/03 15:43:53 | Recruitment status Last follow-up date |
|
3 | Update | 2011/04/19 13:56:14 | Recruitment status Last follow-up date |
|
4 | Update | 2021/10/13 21:03:57 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Division name Zip code TEL Last name of contact person Last name of contact person Zip code TEL Organization Division name Address Address Name of primary person or sponsor Institute Institute Organization Organization Organization Category of Funding Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization Organization Address Address Tel |
|
5 | Update | 2021/10/13 21:15:53 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
6 | Update | 2021/10/13 21:20:28 | Date of IRB Last follow-up date |
|
7 | Update | 2021/10/13 21:23:38 | Name of primary person or sponsor Institute Institute Organization Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
8 | Update | 2021/10/13 21:35:39 | Publication of results Number of participants that the trial has enrolled |